Stay up to date on the issues impacting the industry and be the first to hear about news and changes at Rael & Letson.
The current administration is looking to make many popular drugs more accessible. Could these efforts impact your pharmacy benefit plan?
Read moreIFEBP continues to be one of the biggest and best gatherings of trustees, administrators, vendors, consultants and other industry experts.
Read moreThere is a gap between mental health coverage and actual care received. Consider these strategies to provide access to effective, affordable, timely care.
Read moreWe are excited to announce that Rael & Letson has successfully completed a SOC 2 Type II audit and received our audit certificate.
Read moreMajor developments around fiscal year returns, inflation, and CalPERS reporting could affect public agencies in California over the coming years.
Read moreBefore replacing a wellness program or vendor, you might want to check your communications. Even the best programs can face low engagement when there is poor or confusing outreach or issues accessing services.
Read moreWe are excited to welcome Doug Pryor, ASA, EA, MAAA, to our Retiree Health team to head up our work for public plans.
Read moreDrug rebates are meant to lower costs, but limited transparency and misaligned incentives raise questions. Learn how employers can evaluate PBM practices and ensure their plan delivers real value and long-term savings.
Read moreInterest in psychedelic-assisted therapy is rising, but coverage in multiemployer plans remains rare. Learn how sponsors can evaluate this evolving space—and why communication is key to improving access, safety, and awareness.
Read moreResearch shows that health care utilization—not just high prices—is the main driver of spending variation across U.S. counties. Learn how plan sponsors can address both cost and volume to improve value, and why local patterns matter more than ever.
Read more